QGEN·NYSE·US
QIAGEN
QIAGEN is a life-sciences and molecular diagnostics company that sells sample preparation products, assay technologies, diagnostic tests, and related instruments. It also offers bioinformatics and genomic interpretation software and services through its Digital Insights business.
Recent Activity
Updated Oct 24, 2026
–Buyout firm EQT agreed to acquire Qiagen for $10.8 billion.
Past updates are part of the Pro plan.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.